Malignant ascites enhance γδ T cell cytotoxicity toward ovarian cancer via chemokine-mediated recruitment

QR Code

Malignant ascites enhance γδ T cell cytotoxicity toward ovarian cancer via chemokine-mediated recruitment

Saved in:

Bibliographic Details
Main Authors:	Zhanqun Yang, Ying Liu, Mengzhu Zheng, Hui Li, Ruoyao Cui, Pan Wang, Tianhui He, Hongyan Guo, Yinglin Zhou, Jian Lin, Long Chen
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2025-06-01
Series:	Cancer Biology & Medicine
Online Access:	https://www.cancerbiomed.org/content/22/6/639
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ovarian cancer, malignant ascites and microenvironment. Literature review
by: O. I. Aleshikova, et al.
Published: (2023-07-01)

IL-8 and WISP1 in the molecular characteristics of malignant ascites in ovarian cancer
by: T. V. Abakumova, et al.
Published: (2024-07-01)

Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites
by: Juan Sun, et al.
Published: (2017-11-01)

Diagnostic Value of Ascitic Tumor Markers for Gastric Cancer-associated Malignant Ascites
by: Yaewon Yang, et al.
Published: (2022-03-01)

Ascites as a subject of studies in ovarian cancer
by: A. B. Villert, et al.
Published: (2019-02-01)

Usefulness of Tumor Markers in Ascitic Fluid for the Diagnosis of Gastric Cancer-associated Malignant Ascites
by: Jin Lee
Published: (2022-03-01)

CXC chemokine ligand 1 mediates adiponectin-induced angiogenesis in ovarian cancer
by: Yung-Taek Ouh, et al.
Published: (2019-04-01)

Macrophage fatty acid metabolism under chronic hypoxia shapes γδ T cell recruitment via CCL22
by: Vanesa M. Guerrero Ruiz, et al.
Published: (2025-08-01)

Dissimilar tumor cell populations in ascitic fluid of ovarian cancer patients
by: E. V. Kaigorodova, et al.
Published: (2020-04-01)

Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor
by: V. G. Bespalov, et al.
Published: (2016-02-01)

Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer
by: Sisi Deng, et al.
Published: (2025-05-01)

Ascitic ovarian cancer is an adequate preclinical model of carcinomatosis to study intraperitoneal chemoperfusion treatment
by: G. S. Kireeva, et al.
Published: (2019-02-01)

Markers of Primary Chemoresistance of Epithelial Ascites Cells in Patients with Ovarian Cancer Guidelines for Practitioners
by: D. R. Dolgova, et al.
Published: (2020-05-01)

Characteristics and significance of γδ T cells in colorectal cancer
by: Henna Karjalainen, et al.
Published: (2025-12-01)

EXPERIENCE WITH INTRAPERITONEAL CHEMOTHERAPY USING ASCITIC FLUID AS A SOLVENT OF CHEMICALS IN THE TREATMENT OF OVARIAN CANCER
by: Yu. S. Sidorenko, et al.
Published: (2014-09-01)

Chemokines in Glioma Progression
by: Locatelli, Marco, et al.
Published: (2011)

THE ROLE OF CHEMOKINES IN FIBROMYALGIA
by: Tuba Tülay Koca, et al.
Published: (2025-03-01)

GAMMA DELTA (γδ) T CELLS: ORIGIN, PHENOTYPE, FUNCTIONS
by: Dmitry Sokolov
Published: (2019-08-01)

Mechanisms and Functions of γδ T Cells in Tumor Cell Recognition
by: Jing Tang, et al.
Published: (2025-06-01)

EXPRESSION OF mRNAS FOR CHEMOKINES AND CHEMOKINE RECEPTORS IN THE SKIN FROM PATIENTS WITH PSORIASIS
by: A. S. Beltiukova, et al.
Published: (2014-07-01)

Indwelling peritoneal and pleural catheters in the management of malignant and non-malignant ascites and pleural effusion: experiences from a Danish tertiary center
by: Amalie Thøgersen, et al.
Published: (2025-12-01)

Pancreatic Ascites and Pleural Effusion
by: Prakash, K.
Published: (2012)

The role of γδТ- and NK-сells in immune response
by: Ye. G. Churina, et al.
Published: (2010-10-01)

γδT cells in patients with tumors of the nasal cavity and paranasal sinuses
by: D. B. Nizheharodava, et al.
Published: (2023-11-01)

A dual nature of γδ T cell immune memory responses
by: Tsz Kin Suen, et al.
Published: (2025-07-01)

MALIGNANT OVARIAN TUMORS DIAGNOSTICS DIFFICULTIES
by: S. O. Nikoghosyan, et al.
Published: (2018-08-01)

New verification possibilities for ovarian malignancies
by: A. E. Protasova, et al.
Published: (2014-08-01)

Metabolomic profile of malignant ovarian tumors
by: F. E. Filippov, et al.
Published: (2024-09-01)

Chemokines and Viral Infections of the CNS
by: Durrant, Douglas M., et al.
Published: (2011)

Ability of the sonoelastometria for deferential diagnosis of malignant and non-malignant ovarian tumors
by: L. A. Ashrafyan, et al.
Published: (2014-07-01)

Heterogeneity of EpCAM-positive cells in low-grade serous ovarian carcinoma ascitic fluid: a clinical case
by: E. V. Kaigorodova, et al.
Published: (2022-01-01)

Pressurized intraperitoneal aerosolized chemotherapy clinical efficacy in the combined treatment of newly diagnosed ovarian cancer with peritoneal carcinomatosis and ascites
by: A. S. Dzasochov, et al.
Published: (2024-12-01)

Comparative assessment of the exosomal tumor-associated microRNA levels in blood plasma and ascitic fluid in ovarian cancer patients
by: E. I. Dzhugashvili, et al.
Published: (2023-07-01)

Regulatory TCRαβ+ Double Negative T Cells Suppress γδ T Cells and Alleviate ColitisSummary
by: Mingyang Li, et al.
Published: (2025-01-01)

SURGICAL TREATMENT OF POSTTRAUMATIC CHYLOUS ASCITES
by: B. Y. Sokolov, et al.
Published: (2018-01-01)

Role of Cytokines and Chemokines in HIV Infection
by: Venketaraman, Vishwanath, et al.
Published: (2011)

Stem cell properties of cancer cells in ascitic fluid of patients with ovarian cancer: a key to control over cancer progression
by: O. I. Kovalev, et al.
Published: (2023-07-01)

Dissimilar populations of EpСam-positive cells in ascitic fluid of ovarian cancer patients: a relationship with the degree of carcinomatosis
by: E. V. Kaigorodova, et al.
Published: (2021-07-01)

EPCAM+CD45+ cells in ascitic fluid of patients with ovarian cancer: a relationship with tumor marker levels and tumor grade
by: A. V. Kozik, et al.
Published: (2022-11-01)

NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer
by: Joanna Palade, et al.
Published: (2025-07-01)